Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $32 to $38.
4 Coinbase Analysts Have Mixed Feelings On Q2 Earnings: Are There Glimmers Of Hope?
Cryptocurrency platform Coinbase Global Inc (NASDAQ: COIN) reported second-quarter financial results after market close Tuesday. Here’s what analysts are saying about the company, the crypto bear market and what’s ahead.
